Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

FK-224 research update

July 26, 1996

Tryptase inhibitors described as immune-based inflammatory disorders treatment

July 26, 1996

Anti-IgE monoclonal antibody lawsuits settled

July 19, 1996

Kyoto Pharm. and Asahi Chem. to codevelop AKY-953

July 19, 1996

5-Lipoxygenase inhibitors reported by Pfizer

July 19, 1996

Icos granted U.S. patent for rPAF-AH

July 12, 1996

Torii and Hisamitsu disclose elastase inhibitors

July 12, 1996

APC-366 covered under U.S. patent

July 12, 1996

WAY-126120: Selective PDE IV inhibitor

July 12, 1996

Novel 5-lipoxygenase inhibitors described by Pfizer

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...